Nuffield launches 'personalised healthcare' report
The UK's Nuffield Council on Bioethics has reported that direct-to-consumer personal genetic profiling services used to predict people's genetic susceptibility for common diseases, such as Parkinson's and diabetes, are often inconclusive, misleading and can potentially cause unnecessary anxiety, complacency or distress when no treatment is available...
Comment
Stem cell tourism - don't believe the hype
by Claire Bale and 1 others
Thousands of people with serious, long term health conditions are tempted abroad each year by untested stem cell treatments. Untested stem cell treatments for Parkinson's are available in several countries, including clinics in Germany and China. But the treatments are expensive - often many thousands of pounds - and come without any scientific evidence that they work and with real risks...
We need a code of practice for cross-border reproductive care
by Dr Françoise Shenfield1
Cross-border reproductive care is becoming more widespread, but is fraught with safety concerns. We at the European Society of Human Reproduction and Embryology (ESHRE) have no objection to patients seeking reproductive treatments outside their home country. But to protect patient safety, we believe there should be a Code of Practice (COP) to protect patients, donors and potential surrogates...